
Urologic oncology @BrighamSurgery @BWHUrology @DanaFarber_GU via @UrologyMSK @UTSWUrology
Boston, MA
Joined March 2016
- Tweets176
- Following940
- Followers799
- Likes2.4K
Tim Clinton retweeted
Join us on Tuesday, September 29 at 7pm ET as Tim Clinton, MD, (@ClintonTim) recaps notable data presented at the 2026 Northeastern Section of the AUA Annual Meeting. #NSAUA26
Stay tuned! 🎙️ xitter.cf/i/broadcasts/1PKqrNkAE…
Tim Clinton retweeted
Looking forward to @BladderCancerUS BCAN Think Tank this week; presenting at the “Less Is More” breakout session chaired by @bergsa83 and @ClintonTim
Excited to discuss how evidence is reshaping treatment de-escalation #BCANThinkTank @Parminder1699 @PGrivasMDPhD @MonikaJoshimd
Tim Clinton retweeted
A decade of work comes to fruition. Better care for our patients with high risk prostate cancer. Both primary endpoints positive. Congrats to the entire team and recognition to all our patients who participated @MGHUrology @MassGenBrigham @MGBUrology @DanaFarber_GU
Presented at #ASCO26:
In high-risk localized prostate cancer, ADT plus apalutamide led to a pathological complete response or minimal residual disease and 5-year metastasis-free survival in a greater percentage of patients than ADT plus placebo. Full phase 3 PROTEUS trial results: nej.md/3RuNe00
Editorial: A Watershed Moment in the Perioperative Treatment of Prostate Cancer nej.md/4dLeiiW
@ASCO

ALT A survival analysis graph from a study published in the New England Journal of Medicine shows the percentage of patients over time in months since randomization. The graph compares "ADT plus apalutamide" to "ADT plus placebo." Data includes hazard ratios and confidence intervals. The American Society of Clinical Oncology Meeting is mentioned at the top.
Tim Clinton retweeted
#AUA26 @UroOnc session - 3 papers in the past year that influenced my practice: @ClintonTim highlights our @EurUrolFocus paper on the outcomes of rob PC-RPLND for testicular cancer @Hoomandjaladat
Tim Clinton retweeted
WATCH 👀: @ClintonTim of @DanaFarber discusses discusses differences between genders in terms of bladder cancer presentation.
See the whole video here ➡️: hubs.li/Q04fNwqd0
#oncology #blcsm
Tim Clinton retweeted
What they don’t teach you in medical training:
Your patients will continually inspire you with their courage and compassion
Immensely proud of @devonchoi for sharing his story and raising awareness for testicular cancer by running🏃 🌎 2️⃣6️⃣. 2️⃣!
blog.dana-farber.org/insight…
@ClintonTim @TestesCancer @urotoday @_backtableUro @Uromigos @OncBrothers @crisbergerot @DanaFarber @DanaFarber_GU @DrChoueiri @adamkibel_uro
Tim Clinton retweeted
Testicular Cancer Conference Boston 2025 Presented by @FennecPharma was an incredible and truly awe-inspiring experience.
On behalf of our entire team at the Testicular Cancer Awareness Foundation, thank you again for being part of this milestone event.
Sincere appreciation and gratitude! Honorary Speaker @DrDarrenFeldman Lead Chair @ClintonTim Lindsay Frazier, MD @RichMatulewicz @bergsa83 Pierre Sayad,
PhD, MS, Lydia Chevalier, PhD, Christopher Recklitis, PhD, MPH, Martin Kathrins, MD, @KeyanSalari, Dr. Charles Peyton, Keith Hanigan, @Khalid_Alkhatib
Dr. Michael Glover, Dr. Peter Reisz, Dr. Todd Yezefski, & TCAF board member Sean Q Kern, MD., @aloktewar
Anthony Spina, FNP, Jesse Solomon, T. Clark Gamblin, MD, MS, MBA, @BjComedy @stevencrocker @hrbekroenick
Special thanks as well to @MassGenBrigham @DanaFarber @Harvard & @harvardmed for the great collaborative effort.
A heartfelt thank-you to our generous sponsors: @FennecPharma, @Natera, @MassGenBrigham, Thompson Philanthropic Trust, Flagstone Foods & Emerald Nuts, and Oddballs Funguy.
We’re so proud of what we accomplished together and the meaningful work being done to support patients, survivors, and caregivers while advancing knowledge of the most innovative testing and treatments that enhance quality of life beyond cancer.
#testicularcancer #urology #UroSoMe #menshealth #survivorship
Tim Clinton retweeted
We are excited to announce @CarvalhoFilipeL as our 2025 Rising Stars in Urology Research Awardee! His groundbreaking work targets immune cells that hinder bladder cancer treatment, paving the way for more effective, personalized therapies.
Read more 👉 bit.ly/47m3Zic
Tim Clinton retweeted
Replying to @TestesCancer
@TestesCancer Boston Annual meeting , @DrDarrenFeldman @MSKCancerCenter taking the stage ! Thanks to @ClintonTim as conference chair @DanaFarber_GU
Tim Clinton retweeted
Are you a testicular cancer patient, survivor, caregiver or tc medical provider?
Our 10th annual Testicular Cancer Conference presented by @FennecPharma
is soon approaching - register today!
Special thanks to
@BrighamMass @DanaFarber @Harvard
Click link to register today - testicularcancerawarenessfou…
#testicularcancer #urology #urosome #medonc
Tim Clinton retweeted
Excited to see our paper in print @EUplatinum: europeanurology.com/article/…
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Tim Clinton retweeted
Dominic Gross: From Fighting Crime to Beating Cancer
Welcome to episode 76
In this episode of It Takes Balls, Dominic Gross, an FBI special agent and testicular cancer survivor, shares his journey from diagnosis to recovery.
Dominic first noticed something was off while going through intense SWAT training, experiencing pain and swelling that he initially brushed aside. Struggling to find a primary care provider, he eventually secured an appointment, which led to a quick series of tests confirming his diagnosis.
His treatment included surgery, chemotherapy, and an RPLND surgery with Dr. Tim Clinton @ClintonTim each presenting its own set of physical and emotional challenges.
#testicularcancer #urology #menshealth
Link in comments ⬇️
Tim Clinton retweeted
Join us: annual Shelby Webster #testicularcancer conf @MethodistHosp Feb 20-21. Case based mtg, virtual/in person @nabiladra - VP guest speaker.
Chris Porter @KKseattle @Testiscancer @ClintCaryMD @AdityaBagrodia @GU_BigWhacks @UroAlsyouf @uroegg @drphil_urology @RHamiltonUrol
Tim Clinton retweeted
primary RPLND in CSIIa/b germ cell tumours+-adjuvant chemotherapy in >300 men, largest cohort published
📊 1/3 had no cancer in removed nodes, cave overtreatment
🎯 Larger marker neg nodes predict teratoma, resection in selected 2b
💉 2 cycles adj chemo after surgery at max
Tim Clinton retweeted
What an incredible evening at our Docs Meet & Greet Social at the 25th Annual Society of Urological Oncology Conference in Dallas, Texas.
A total of 48 people gathered including some of the top testicular cancer surgeons in the country, and many other TC medical experts attended this private event hosted by the Testicular Cancer Awareness Foundation and sponsored by @FennecPharma
These events help bring together TC medical experts sharing important information with one another as well as learning about all the amazing programs that TCAF has to offer their patients.
Together we are making such a positive impactful difference in the fight against testicular cancer.
We are incredibly grateful for the continued support of Fennec Pharmaceuticals for events such as this including our annual TC Conferences.
Fennec offers the first and only FDA approved hearing loss prevention for adolescence and young adults (AYA) who receive cisplatin chemotherapy to help reduce ototoxicity (hearing loss).
Fennec’s hearing loss drug, Pedmark is also recommended by the NCCN guidelines for patients 15-39 years of age.
If you are about to start treatment for testicular cancer that includes cisplatin chemotherapy, contact Fennec HEARS at 1-833-7PEDMARK or 1-(833)-773-3627
#testicularcancer #testescancer #testicularcancerawareness #urology #SUO2024 #hearlossprevention #tcsurvivor #patientsupport #patientadvocacy #malecancer #harvard #duke #johnshopkins #ucsdhealth #usc #msk #penn
Tim Clinton retweeted
In today’s episode of It Takes Balls, Dr. Tim Clinton talks about performing minimally invasive retroperitoneal lymph node dissections (RPLND), how robotic RPLND compares to open RPLND, risks involved with both options, how candidates are selected for robotic RPLND, and more!
Links in 🧵
#testicularcancer #testiscancer #urology #MensHealth #urosome
Tim Clinton retweeted
@TestesCancer conference wrap up w/ ask the providers featuring @ClintonTim @DanaFarber @BWHUrology @IUuro #Tim Masterson @KimJonesTCAF @BjComedy and Bocce ball tournament! @drphil_urology @UCSD_Urology
Tim Clinton retweeted
Woo!!! Years of hard work in the making. @TheJEADV @SpiessPhilippe @ClintonTim
Factors predictive of recurrence, metastasis and death in node‐negative penile squamous cell carcinoma: A retrospective multicentre cohort study onlinelibrary.wiley.com/doi/…
Tim Clinton retweeted
Wonderful turnout for our Whitmore alumni event at #AUA24 !
















































